- Global Pharma News & Resources

Press Releases - 2020-06-12

Date Title Company
12-Jun-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
12-Jun-2020 Sun Pharma Presents ODOMZO® and LEVULAN® KERASTICK® + BLU-U® Data, Offering Clinical Insights for Treating People with or at Risk of Skin Cancer Sun Pharmaceutical Industries Ltd.
12-Jun-2020 First Presentations of Bimekizumab Phase 3 Data Demonstrate Superior Skin Clearance Over Placebo and Stelara® at Week 16 in Adults with Moderate-to-Severe Plaque Psoriasis UCB, Inc.
12-Jun-2020 PANTHERx® Chosen as Exclusive Rare Pharmacy Partner by Viela Bio, Inc. for Uplizna(TM) (inebilizumab-cdon) for Adult Patients with AQP4+ Neuromyelitis Optica Spectrum Disorder (NMOSD) PANTHERx Rare Pharmacy
12-Jun-2020 Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation Mydecine Innovations Group Inc.
12-Jun-2020 QBioMed to Support and Exhibit at Living Beyond Breast Cancer 2020 Virtual Conference on June 13-14, 2020 Q BioMed Inc.
12-Jun-2020 AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020 AstraZeneca
12-Jun-2020 AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress AstraZeneca
12-Jun-2020 Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage Amolyt Pharma
12-Jun-2020 Major New Contract Signed Open Orphan plc
12-Jun-2020 Drone Software Market to Witness Robust Expansion Throughout the Forecast Period 2019 – 2030 Market Industry Reports
12-Jun-2020 RHÖN-KLINIKUM Aktiengesellschaft: Advanced negotiations on termination of the employment contract of the Chairman of the Management Board RHÖN-KLINIKUM Aktiengesellschaft
12-Jun-2020 Jazz Pharmaceuticals Announces the Poster Publication of Vyxeos® Liposomal (daunorubicin and cytarabine) Long-Term Phase 3 Data for Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukaemia at EHA Annual Congress Jazz Pharmaceuticals plc
12-Jun-2020 ZZ Biotech Announces FDA Fast Track Designation for Stroke Program ZZ Biotech, LLC
12-Jun-2020 Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress Pivotal AUTO1 study in adult ALL patients enrolling Autolus Therapeutics plc
12-Jun-2020 Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies Zelluna Immunotherapy
12-Jun-2020 RDIF and ChemRar deliver first batch of Avifavir antiviral drug to Russian hospitals The Russian Direct Investment Fund
12-Jun-2020 FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf) Pfizer Inc
12-Jun-2020 Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners
12-Jun-2020 Onyx Health Launch VR Learning Platform in Response to COVID-19 Onyx Health